Volume 2 Issue 3

Review

Rubber Elongation Factor and Natural Allergy-Oncology

Michael J Dochniak*

The natural allergy-oncology perspective described herein explores how forced immunity to allergens from the rubber tree Hevea brasiliensis may inhibit tumor growth and metastasizing. The over expression of mast cells and proteins from the Rho family of GTPases has been shown to manifest in PDF

Research

Light and breast cancer: Is there any relationship

Pushkala K1 and Gupta P. D2*

Breast cancer is the leading cause of death in women all over the world. Epidemiological survey for the incidence of breast cancer in Scandinavian countries and night shift workers provide enough evidence for the possible relation between light and hormone regulated cancers such as breast cancer and prostate PDF

Case Review

Response to Afatinib, an Irreversible EGFR-TKI in a Patient with Advanced Squamous Carcinoma of lung

Ruchir Tandon*

Advanced squamous cell carcinoma of the lung, accounts for 20-30% of cases of non-small-cell lung cancer [1]. After the failure of first-line platinum-based doublet chemotherapy, there are very few treatment options available to patients suffering from advanced PDF

Case Report

Response to Afatinib, an Irreversible EGFR-TKI in a Patient with Advanced Squamous Carcinoma of lung

Ruchir Tandon*

Advanced squamous cell carcinoma of the lung, accounts for 20-30% of cases of non-small-cell lung cancer [1]. After the failure of first-line platinum-based doublet chemotherapy, there are very few treatment options available to patients suffering from PDF

Research

Not all Imatinib treated Chronic Myeloid Leukemia Patients with BCR-ABL1 more than 10% at 3 Months have Unsatisfactory Outcome

Nahla A M Hamed1*, Iman Attia1 , Sheimaa Sherif2 , Mohamed Elhusseini3

Outcomes are heterogeneous among chronic myeloid leukemia chronic phase (CML CP) patients with BCR-ABL1 transcript percent>10% at 3 months and some have satisfactory outcomes. NCCN guidelines include a change of CML PDF